1. Home
  2. GDTC vs ANY Comparison

GDTC vs ANY Comparison

Compare GDTC & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • ANY
  • Stock Information
  • Founded
  • GDTC 2018
  • ANY N/A
  • Country
  • GDTC Singapore
  • ANY United States
  • Employees
  • GDTC N/A
  • ANY N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • GDTC Health Care
  • ANY Finance
  • Exchange
  • GDTC Nasdaq
  • ANY Nasdaq
  • Market Cap
  • GDTC 24.8M
  • ANY 23.8M
  • IPO Year
  • GDTC 2023
  • ANY N/A
  • Fundamental
  • Price
  • GDTC $1.95
  • ANY $0.57
  • Analyst Decision
  • GDTC
  • ANY Strong Buy
  • Analyst Count
  • GDTC 0
  • ANY 1
  • Target Price
  • GDTC N/A
  • ANY $3.00
  • AVG Volume (30 Days)
  • GDTC 268.9K
  • ANY 1.2M
  • Earning Date
  • GDTC 01-01-0001
  • ANY 11-04-2025
  • Dividend Yield
  • GDTC N/A
  • ANY N/A
  • EPS Growth
  • GDTC N/A
  • ANY N/A
  • EPS
  • GDTC N/A
  • ANY N/A
  • Revenue
  • GDTC $573,193.00
  • ANY $11,099,000.00
  • Revenue This Year
  • GDTC $5.37
  • ANY N/A
  • Revenue Next Year
  • GDTC N/A
  • ANY $36.07
  • P/E Ratio
  • GDTC N/A
  • ANY N/A
  • Revenue Growth
  • GDTC 63.03
  • ANY N/A
  • 52 Week Low
  • GDTC $1.65
  • ANY $0.36
  • 52 Week High
  • GDTC $4.05
  • ANY $1.90
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 42.90
  • ANY 34.05
  • Support Level
  • GDTC $1.68
  • ANY $0.68
  • Resistance Level
  • GDTC $3.10
  • ANY $0.75
  • Average True Range (ATR)
  • GDTC 0.34
  • ANY 0.07
  • MACD
  • GDTC -0.06
  • ANY -0.03
  • Stochastic Oscillator
  • GDTC 14.96
  • ANY 6.95

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: